Stay updated on Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.

Latest updates to the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedAdds current date and study status; removes an older date to update the timeline. Overall, it updates time-sensitive content and core status information.SummaryDifference0.7%
- Check18 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference7%
- Check25 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.2%
- Check39 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, and the Back to Top element has been removed.SummaryDifference0.4%
- Check47 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.4%
- Check54 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity and relevance of the page's content.SummaryDifference85%
Stay in the know with updates to Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.